Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Influenza vaccines and influenza antiviral drugs in Africa: Are they available and do guidelines for their use exist?
BMC Public Health, Volume 14, No. 1, Article 41, Year 2014
Notification
URL copied to clipboard!
Description
Background: Influenza viruses cause significant morbidity and mortality in Africa, particularly among high-risk groups, but influenza vaccines and antiviral drugs may not be commonly available and used. The main aim of this study was to determine the availability and use of influenza vaccines and antiviral drugs as well as to describe existing related guidelines and policies in Africa. Methods. A self-administered survey was distributed among key influenza experts in 40 African countries. Results: Of the 40 countries surveyed, 31 (78%) responded; 14/31 (45%) reported availability of seasonal influenza vaccine, and 19/31 (65%) reported availability of antiviral drugs for the treatment of influenza. Vaccine coverage data were only available for 4/14 (29%) countries that reported availability of seasonal influenza vaccine and ranged from <0.5% to 2% of the population. Conclusions: Influenza vaccines and antiviral drugs are available in many countries in Africa but coverage estimates are low and remain largely unknown. Describing the local burden of disease and identifying funding are essential to encourage countries to use influenza vaccine more widely. © 2014 Duque et al.; licensee BioMed Central Ltd.
Authors & Co-Authors
Duque, Jazmin
United States, Atlanta
Centers for Disease Control and Prevention
United States, Columbus
Battelle
McMorrow, Meredith Lynn
United States, Atlanta
Centers for Disease Control and Prevention
United States, Rockville
Us Public Health Service
Cohen, Adam Lauren
United States, Atlanta
Centers for Disease Control and Prevention
United States, Rockville
Us Public Health Service
South Africa, Pretoria
Centers for Disease Control and Prevention, South Africa
Statistics
Citations: 39
Authors: 3
Affiliations: 4
Identifiers
Doi:
10.1186/1471-2458-14-41
e-ISSN:
14712458
Research Areas
Health System And Policy
Study Design
Cross Sectional Study
Study Approach
Quantitative